WHO investigates a possible narcolepsy risk in GSK's Pandemrix - Related Stories - AAP SmartBrief
Links shared publicly online about this topic.
- 535total visits
WHO investigates a possible narcolepsy risk in GSK's Pandemrix - Related Stories - AAP SmartBrief
The World Health Organization launched a safety review of GlaxoSmithKline's Pandemrix in light of a Finnish study indicating that the H1N1 flu vaccine contributed to narcolepsy in people ages 4 to 19 in 2009 and 2010. Last year, the European Medicines Agency said it found no evidence that validates
View full resource at smartbrief.com
Tags: H1N1, Sleep Disorder, Narcolepsy, Healthy Living, American Academy of Pediatrics, GlaxoSmithKline, Safety
Most Recently Shared on February 2, 2011 at 10:16 pm By:
WHO investigates a possible narcolepsy risk in GSK's Pandemrix http://sbne.ws/r/6F2e
Advertisement
